Anesthesia Information Management System Vendor Security Risk Assessment Checklist

How should AIMS data protection and access controls be assessed?

Start by identifying what protected health information (PHI) the anesthesia information management system (AIMS) creates, receives, maintains, or transmits; where it is stored; and which users, services, devices, and vendors can access it. Include production, test, support, backup, and disaster-recovery environments. HIPAA’s Security Rule calls for a risk analysis covering the confidentiality, integrity, and availability of electronic PHI (ePHI), including ePHI handled by vendors. See HHS guidance on HIPAA risk analysis.

• Protected health information encryption: Ask how the vendor protects ePHI at rest and in transit, including database storage, backups, mobile devices, and interfaces. Request details about encryption protocols, key ownership and rotation, and access to decryption keys. HIPAA treats encryption as an addressable implementation specification: the organization must assess whether it is reasonable and appropriate, document its decision, and implement an equivalent alternative when appropriate if encryption is not used. See HHS guidance on encryption under the Security Rule and HHS guidance on addressable specifications.
• Role-based access control: Check whether permissions can be limited by job function and scope—for example, clinician, anesthesia technician, administrator, and vendor support. Confirm that access can be promptly granted, changed, and revoked; that shared accounts are restricted; and that emergency access is controlled and reviewable.
• Privileged access multifactor authentication: Ask whether administrators, remote support staff, and other privileged users must use multifactor authentication, and how privileged sessions are approved, limited, monitored, and ended. Treat MFA as a risk-based control to validate for the deployment, rather than assuming HIPAA prescribes this exact technology for every account.
• Verify unique user identification, authentication, session timeout options, and procedures for workforce termination or role changes. HIPAA requires unique user identification and person-or-entity authentication; other access-control specifications depend on the organization’s risk assessment. See the HIPAA Security Rule technical safeguards.
• Confirm that the vendor can restrict its workforce from viewing live patient data unless access is authorized and needed, and can explain how customer approval, temporary access, and support-session records work.

What security assurance evidence should AIMS vendors provide?

Request evidence that is relevant to the AIMS service, the data it handles, and the proposed hosting and support model. HIPAA requires appropriate safeguards and a business associate agreement when the vendor acts as a business associate; it does not prescribe a specific vendor certification or require a particular audit report. HHS notes that customers may seek additional assurances through a BAA, service-level agreement, or other contract based on their risk analysis. See HHS guidance on HIPAA and cloud computing.

• Request the scope, period, and relevant findings of independent security assessments, such as a SOC 2 report or an applicable ISO certification. Check whether the report covers the AIMS product, hosting environment, and key subcontractors—not just the vendor’s corporate offices.
• Ask for a recent vulnerability assessment or penetration-test summary, the testing scope and methodology, identified material findings, remediation status, and any exceptions. Vulnerability scanning and penetration testing are useful assessment evidence; do not present either as a standalone HIPAA certification.
• Review security policies and procedures relevant to access, encryption, secure development, change management, workforce training, incident response, data retention, and third-party access. Request evidence that the controls are operating, not only policy statements.
• Ask for a system and data-flow diagram that identifies hosting locations, trust boundaries, interfaces, remote support paths, and subcontractors that may create, receive, maintain, or transmit PHI.
• Confirm how the vendor reports significant assessment findings and material security changes during the contract. If reports are restricted, agree on a practical alternative, such as a confidential review, a qualified independent attestation, or a focused questionnaire with supporting evidence.
• Assess exceptions, open findings, and compensating controls in context. A report or certificate is evidence to evaluate—not proof that the AIMS deployment is secure or that the healthcare organization itself is HIPAA compliant.

How should AIMS audit logging and monitoring be evaluated?

HIPAA requires audit controls that record and examine activity in systems containing or using ePHI, but the Security Rule does not prescribe one universal event list or log format. Evaluate whether the AIMS records enough reliable detail to detect inappropriate activity and investigate patient-safety, privacy, and security concerns. See the HIPAA Security Rule audit-control requirement.

• Ask whether logs capture successful and failed authentication, user and administrator actions, access to or changes in patient records, exports, configuration changes, emergency access, and vendor support activity where applicable.
• Check whether each relevant event can be associated with a unique user or service identity, a timestamp, and the affected record or function. Ask how the system protects logs from alteration and whether clock synchronization supports accurate event reconstruction.
• Review how the vendor monitors suspicious activity, triages alerts, escalates incidents, and notifies the customer. Clarify which party reviews AIMS activity and which party is responsible for investigating alerts.
• Ask whether logs can be searched and exported promptly in a usable format, and whether they can be correlated with identity-management, endpoint, network, and security-monitoring systems.
• Set log-retention, access, and delivery expectations in the contract or security schedule based on organizational, legal, and investigative needs. Do not assume HIPAA’s documentation-retention rule automatically sets a specific retention period for every technical audit log.
• For EHR interface audit logging, verify that the AIMS and connected EHR record interface activity, message failures, retries, and relevant changes in a way that supports tracing a transaction across systems.

What incident response and breach notification requirements should contracts define?

Ask the vendor for its incident-response process, escalation contacts, and procedures for preserving evidence and containing an event. A BAA must require a business associate to report security incidents of which it becomes aware, including breaches of unsecured PHI. For a breach of unsecured PHI, HIPAA requires the business associate to notify the covered entity without unreasonable delay and no later than 60 calendar days after discovery; a contract may set a shorter operational deadline. See HHS’s HIPAA Security Rule summary and 45 CFR § 164.410.

• Define what the vendor must report, including suspected security incidents, confirmed breaches, unauthorized access or disclosure, service compromise, and incidents involving subcontractors. Distinguish prompt contractual notice of potential incidents from the legal breach-notification process.
• Set a clear notice deadline for security incidents and suspected breaches, with a designated 24/7 contact method where appropriate. A shorter contractual deadline can give the organization time to assess the event and meet its own obligations.
• Specify the information and updates the vendor must provide, such as known affected systems, data types, approximate scope, discovery timeline, containment actions, investigation status, and information needed to identify affected individuals. Require updates as facts become available.
• Allocate responsibilities for investigation, evidence preservation, risk assessment, regulatory and individual notifications, patient communications, and regulator cooperation. The covered entity should retain control of decisions and notices that are its responsibility.
• Require the vendor to coordinate response activities, preserve relevant logs and records, support forensic review, and ensure its subcontractors promptly report incidents to it.
• Document escalation paths, communication channels, and post-incident corrective-action reporting in the BAA or related contract. A BAA’s required elements are described in 45 CFR § 164.504.

How should vulnerability management, backups, and disaster recovery be validated?

Review how the vendor identifies, prioritizes, remediates, and verifies vulnerabilities in the AIMS application, operating systems, databases, and supporting infrastructure. Ask for written severity-based remediation targets, patch and change procedures, and examples of how overdue or disputed findings are escalated. The specific review cadence and service targets should reflect the deployment’s risk and be agreed with the vendor.

• Confirm that vulnerability scanning covers the relevant production and supporting environments, and ask how the vendor manages authenticated scanning, remediation verification, exceptions, and emergency patching. Request evidence of penetration testing and remediation without treating testing as proof that no vulnerabilities remain.
• Ask which AIMS data and configurations are backed up, how often, where copies are stored, and how access to and deletion of backups are controlled. Verify that backups are retrievable and protected against unauthorized alteration or loss.
• Review documented restoration steps and evidence from disaster recovery restore testing. Ask what was restored, when the test occurred, whether it met the agreed recovery objectives, what problems arose, and how corrective actions were tracked.
• Agree on recovery time and recovery point objectives, service priorities, and downtime procedures that fit anesthesia operations. These are useful contractual targets to negotiate; do not characterize specific recovery times as universal HIPAA deadlines.
• Check how the vendor will support continued critical operations if the AIMS or a dependent service is unavailable, including access to necessary information and communication with clinical and technical teams.

HIPAA requires contingency planning that includes a data backup plan, disaster recovery plan, and emergency mode operation plan. Testing and revision procedures are an addressable specification and should be assessed and documented in light of the organization’s circumstances. See 45 CFR § 164.308 and HHS guidance on administrative safeguards.

What data handling and contract terms should the checklist cover?

If the AIMS vendor creates, receives, maintains, or transmits PHI on behalf of a covered entity, determine whether it is acting as a business associate and whether a BAA is required. A BAA does not replace the organization’s own risk assessment or vendor oversight. See HHS guidance on business associates.

• Define permitted uses and disclosures, the vendor’s safeguard obligations, security-incident reporting, cooperation with the covered entity, and the vendor’s responsibility for subcontractors handling PHI.
• Identify the data the vendor collects and retains, its purposes, storage and processing locations, and any use of PHI for analytics, product improvement, or other secondary purposes. Require changes to be reviewed and approved under the contract.
• Set requirements for workforce access, confidentiality, security awareness, secure data transfer, and appropriate handling of customer data in support and test environments.
• Specify the customer’s access to relevant security evidence, incident records, and audit information. HIPAA does not expressly require a business associate to give its customer a general right to audit its security practices, so define appropriate assurance and review rights contractually based on the organization’s risk analysis.
• Address return or destruction of PHI at termination, including the process, timing, confirmation, and treatment of backups or other retained copies. Under the BAA rule, PHI must be returned or destroyed when feasible; if that is infeasible, contractual protections must continue and further uses and disclosures must be limited. See 45 CFR § 164.504.
• Clarify service availability, support responsibilities, security-change notices, termination assistance, and what happens to PHI if the vendor or a key subcontractor stops providing service.

How should AIMS integrations and interface risks be assessed?

Map every connection between the AIMS and the EHR, anesthesia devices, identity-management tools, analytics platforms, laboratories, billing systems, and other services. For each connection, document the data exchanged, its direction, the systems and parties involved, the authentication method, and the owner responsible for monitoring and support.

• Review interface specifications and data flows, including message types, API endpoints, service accounts, transport protections, and any vendor or third-party access. Confirm that production and test connections are separated and that test data is appropriately protected.
• Verify that interfaces authenticate connected systems, restrict access to the minimum necessary functions and data, and protect data in transit. Ask how credentials, certificates, and secrets are issued, rotated, stored, and revoked.
• Check how the AIMS and connected systems handle message validation, duplicate or delayed messages, failed transmissions, retries, reconciliation, and interface downtime. Confirm that errors can be detected and escalated before they create an incomplete or misleading clinical record.
• Assess EHR interface audit logging for traceability across both systems. Confirm that relevant events—such as message receipt, rejection, transformation, retry, and record update—can be linked and investigated without relying on a single system’s logs.
• Require change-control review for new interfaces, material upgrades, authentication changes, and new subcontractors. Reassess the risk when data flows or system dependencies change, rather than relying only on the initial vendor review.

A complete AIMS security decision should combine evidence about data protection, access, monitoring, incident response, recovery, contract obligations, and interfaces—and record open risks, owners, and mitigation steps before deployment and as the service changes.

FAQs.

What evidence should an AIMS vendor provide for a security risk assessment?

Request evidence that matches the AIMS service and its data flows: a system and data-flow diagram, relevant independent assessment reports, vulnerability scanning and penetration-testing summaries, remediation status, access-control and encryption details, incident-response procedures, backup and restore-test results, and a list of relevant subcontractors. Review scope, dates, exceptions, and unresolved findings. HIPAA does not mandate one particular report or certification, so assess the evidence against your organization’s risks.

How should a healthcare organization verify AIMS backup and recovery capabilities?

Review the vendor’s backup and disaster-recovery plans, identify which data and configurations are covered, and examine evidence from actual restore tests. Confirm that restored data is usable and complete, review test findings and corrective actions, and compare results with the recovery time and recovery point objectives agreed for the service. HIPAA contingency planning includes backup, disaster recovery, and emergency-mode operation requirements; see 45 CFR § 164.308.

What should an AIMS business associate agreement specify about breach notification?

It should require the business associate to report security incidents and breaches, describe how quickly and through which channels it must notify the covered entity, and specify the information and continuing updates it must provide. It should also address investigation cooperation, evidence preservation, subcontractor reporting, and allocation of response and notification responsibilities. HIPAA requires notice of a breach of unsecured PHI without unreasonable delay and no later than 60 calendar days after discovery; a contract may establish a shorter deadline. See 45 CFR § 164.410.

How often should AIMS integrations and security controls be reassessed?

Reassess them before go-live, after material changes to the AIMS, connected systems, data flows, or vendor arrangements, and when incidents or new findings change the risk. Schedule periodic reviews appropriate to the organization’s environment as well. HIPAA requires ongoing evaluation and updating of security measures as needed but does not set one universal risk-analysis frequency; see HHS guidance on risk analysis.